Prelude Capital Management’s Bausch Health BHC Stock Holding History

Prelude Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90,000	Closed	-$2.86M	–	1652
2021 Q1	$2.86M	Hold	90,000	–	–	0.07%	219
2020 Q4	$1.87M	Buy	+90,000	New	+$1.68M	0.05%	309
2020 Q3	–	Sell	-800	Closed	-$15K	–	1836
2020 Q2	$15K	Buy	+800	New	+$14.1K	﹤0.01%	1456

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

GCC

Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Prelude Capital Management's BHC Position: Q3 2020 in Review

Prelude Capital Management sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 1,648 shares — an estimated $30K sold.

Prelude Capital Management first reported a position in BHC in Q3 2013 and held it in 18 quarters. The position peaked at $2.79M in Q4 2013. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Prelude Capital Management reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Prelude Capital Management sold 1,648 Bausch Health shares in Q3 2020, an estimated $30K.
Prelude Capital Management first reported a position in Bausch Health in Q3 2013 and held it in 18 quarters.
Prelude Capital Management's Bausch Health position peaked at $2.79M in Q4 2013.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.